All About Hodgkin’s Lymphoma
Posted on March 10, 2008
Hodgkin抯 lymphoma or Hodgkin抯 disease is a rare for of cancer which is characterized by orderly growth of malignant cells of the lymphatic system. Described for the first time by Thomas Hodgkin in 1832, this disease primarily affects the lymph nodes and later spreads to other parts of the lymphatic system.
The most significant characteristic of Hodgkin抯 lymphoma is presence of malignant B-cells with unique characteristics. These cells are called as Reed-Sternberg cells. Hodgkin抯 lymphoma mainly occurs in individuals with depleted immune system and persons infected with viruses including HIV, Epstein-Barr virus and HTLV-I. Epidemiology of this disease is unique. The frequency of Hodgkin抯 lymphoma is predominant in two separate age groups. These include individuals between 15-35 years of age and individuals above 55 years of age.
Hodgkin抯 lymphoma is primarily classified into classical Hodgkin抯 lymphoma (CHL), nodular sclerosis (NS), lymphocyte predominance (LP), mixed cellularity (MC), Lymphocyte depleted (LD) and nodular lymphocyte predominant Hodgkin抯 lymphoma (NLPHL) depending on the Reed-Sternberg cell morphology. The most common symptom of Hodgkin抯 disease is swelling in the lymph nodes of the neck and chest. Other noticeable symptoms include enlarged spleen, swollen liver, fever, excessive sweating, fatigue, abnormal weight loss and itchy skin. The disease could be medically diagnosed through microscopical examination of Reed-Sternberg cells during biopsy. Other diagnostic methods include physical examination, chest X-rays, blood cell counts, and CT scan and MRI scan of the lymphatic system, PET scanning, gallium scanning and bone marrow aspiration.
Hodgkin抯 lymphoma is one of the first cancers to have been cured using radiation therapy. Other therapeutic approaches include chemotherapy, bone marrow and peripheral blood transplantation and immunotherapy. The common chemotherapeutic regimens followed for the treatment of Hodgkin抯 lymphoma include ABVD (Adriamycin, bleomycin, vinblastine, dacarabzine), BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone), COPP/ABVD, MOPP (mechlorethamine, oncovin, procarbazine, prednisone) and Stanford V.
Check Out More Articles:
Lymphoma Misdiagnosis Story, Good Clinical Practice Job Opportunity, Colorectal Cancer Treatment Modalities,
Article Author :Pauline_Go
Last 6 posts in Leukemia Lymphoma Cancer
- Structure and Function of Blood and Bone Marrow - August 25th, 2008
- What Are Leukemias? - August 8th, 2008
- Prevent Leukemia Lymphoma Cancer - August 8th, 2008
- A Client, Not a Patient - August 8th, 2008
- Childhood Leukemia and the Help of Stem Cells - August 8th, 2008
- Chronic Leukemia Surgery - Manage it in India - August 8th, 2008
- Prevent - Leukemia Lymphoma Cancer - July 23rd, 2008
- What is Non-Hodgkins Lymphoma? - July 6th, 2008
- Leukemia For Twins and Stem Cells Solutions - July 6th, 2008
- Blood Cancer - Causes and Treatment - June 10th, 2008
Pain is an unpleasant sensation. Most mesothelioma patients suffer from pain to a certain degree. It can be mild but it can also be acute or chronic. Acute pain is severe pain that comes quickly but usually lasts for a short time. On the other hand chronic pain is more persistent and lasts for a longer period of time. Pain arises both from the tumor itself and from the treatment taken. Chemotherapy, radiation and surgery can cause pain. Perhaps it is chemotherapy drugs that cause the most discomforts.
Chemotherapy usually cause discomforts as much or sometimes even more than pain caused… Continue reading
Perhaps one of the most visible symptoms that an individual has cancer is hair loss. Many patients are very aware and concerned about the loss of their hair. Hair thinning and hair loss is a common side effect of some chemotherapy drugs and radiation therapy. This occurs because chemotherapy drugs damages rapid growing cells such as those of mesothelioma but also other normal rapid growing cells such as that of the hair. However the hair will grow some time after chemotherapy is terminated and it may not necessary be of the same texture or color as was prior to chemotherapy.
There… Continue reading
Chemotherapy drugs can have a temporal effect on the bone marrow and may so cause a reduction in the red blood cells, white blood cells and platelets. If there is a reduction of these cells, the body is easily bruised and bleeding will take longer to stop. White blood cells fight infections and so by a drop in the count of these cells, the body will be less able to fight any infection. Symptoms as headaches, muscle pain, sore throat, a cough, feeling cold and problems in passing urine may be an indication of an infection. It is very important… Continue reading
Related posts
» Filed Under Leukemia Lymphoma Cancer
Comments
Leave a Reply
